Institutional Ownership
Abcellera Biologics Inc
CUSIP 00288U106COMABCLQ1 2026
13D / 13G Filings
19
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
23.0%
Max % of class reported
Institutional Holders
136
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
19 filings · latest Nov 14, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2024 | Baker Bros. Advisors LP | 13G/A | 9.3% | 27.53M | SEC |
| 2 | Oct 9, 2024 | Baillie Gifford &Amp; Co | 13G/A | 4.4% | 12.89M | SEC |
| 3 | Feb 14, 2024 | Baker Bros. Advisors LP | 13G | 7.9% | 22.91M | SEC |
| 4 | Feb 13, 2024 | Hansen Carl L. G. | 13G/A | 20.6% | 60.74M | SEC |
| 5 | Jan 29, 2024 | Baillie Gifford & Co | 13G/A | 8.3% | 24.04M | SEC |
| 6 | Apr 24, 2023 | Thiel Peter | 13D/A | 5.0% | 14.36M | SEC |
| 7 | Feb 13, 2023 | Capital World Investors | 13G/A | 3.3% | 9.33M | SEC |
| 8 | Feb 6, 2023 | Hansen Carl L. G. | 13G/A | 20.4% | 58.99M | SEC |
| 9 | Jan 18, 2023 | Baillie Gifford & Co | 13G | 6.9% | 19.70M | SEC |
| 10 | Feb 14, 2022 | Viking Global Investors LP | 13G/A | — | — | SEC |
9 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Abcellera Biologics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Baker Bros. Advisors LP | 30.28M | $105.66M |
| 2 | Capital World Investors | 13.36M | $46.63M |
| 3 | Two Sigma Investments, LP | 10.56M | $36.86M |
| 4 | Td Waterhouse Canada Inc. | 9.56M | $33.57M |
| 5 | Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas LLC | 7.58M | $26.44M |
| 6 | Ubs Group AG | 4.21M | $14.69M |
| 7 | Arrowmark Colorado Holdings LLC | 4.11M | $14.33M |
| 8 | Blackrock, Inc. | 4.04M | $14.10M |
| 9 | Driehaus Capital Management LLC | 4.02M | $14.05M |
| 10 | Goldman Sachs Group Inc | 3.75M | $13.09M |